24 March 2026 : Review article
Review of the Effects of Anesthetic Techniques and Medications on the Immune Response During the Perioperative Period
Paweł RadkowskiDOI: 10.12659/MSM.951077
Med Sci Monit 2026; 32:e951077
Table 3 Effects of intravenous anesthetics on the immune system [10,23,25–27].
| Effects of intravenous anesthetics on the immune system | |
|---|---|
| Propofol | Modulates mast cell function |
| Alters secretion of IL-4, IL-5, and TNF-α | |
| May impact the character of the postoperative inflammatory response | |
| Etomidate | Modulates GABA-A receptors |
| Reduces perioperative immune and hormonal stress | |
| Increases CD4+ T-cell counts and CD4/CD8 ratio | |
| Decreases IL-6, TNF-α, and IL-8 levels | |
| Increases IL-10 (anti-inflammatory) | |
| Dexmedetomidine | Attenuates proinflammatory signaling |
| Reduces cytokine release | |
| Alters leukocyte activity | |
| Regulates neurotransmitters, oxidative stress and apoptotic pathways | |
| Midazolam | Inhibits LPS-stimulated immune responses in human macrophages |
| Activates TSPO signaling | |
| Suppression of macrophage activity may underlie harmful immunosuppressive adverse effects in critically ill patients | |
| S-ketamine | Noncompetitive NMDA-receptor antagonist |
| Modulates immune responses | |
| When combined with sevoflurane, shows no significant change in postoperative cellular immune function | |
| Remimazolam | Preserves perioperative immune function more effectively than propofol |
| Results in significantly higher NK, CD3+ and CD4+ lymphocyte levels immediately after surgery and at 24 h postoperatively | |
| Source: own. IL-4 – interleukin 4; IL-5 – interleukin 5; TNF-α – tumor necrosis factor alpha; GABA-A – gamma-aminobutyric acid type A; IL-8 – interleukin 8; IL-10 – interleukin 10; NMDA – N-methyl-D-aspartate; LPS – lipopolysaccharide; TSPO – translocator protein. | |






